FDA SECOND ?While the European process is an important first step, Chan said in a jan.20, 2022 news release, MedMira management said U.S. FDA approval of the product would be preferred by current and future customers----- ROGER TAYLOR: Halifax's MedMira focused on cracking U.S. market with COVID testing tech--Roger Taylor | Posted: Jan. 20, 2022, 4:07 p.m. | Updated: Jan. 20, 2022, 7 p.m. | 3 Min Read
-- Medmira has only 3, 4 or 5 main customers- The Company derives approximately 96% (January 31, 2021 – 86%) of its revenue
from five (January 31, 2021 — three) main customers and, for these customers,
assesses the recoverability of each account on a regular basis. During the three
months ended January 31, 2021, customer 1 accounted for
69% of the Company’s
revenue, customer 2 accounted for
11% of the revenue, customer 3 accounted for
9%, customer 4 account for
4% and customer 5 account for
3%. ----------------------------------
I imagine some shareholders like me don't know why the priority is on Europe first -- Hopefully Mr Chan knows what is best